Newsroom

Hovione and Laxxon Medical Partnership Announced

Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications

Laxxon Medical to Participate in the BIO CEO & Investor Conference

NEW YORK, NY / ACCESSWIRE / February 2, 2023 / Laxxon Medical, a pharma-technology company pioneering innovative 3D screen printed...

Laxxon Medical to Participate in 25th Annual Needham Growth Conference

NEW YORK, NY / ACCESSWIRE / January 5, 2023 / Laxxon Medical Corporation announced today their invitation to participate as a private...

Laxxon Medical Granted U.S. Patent for the Sequential Release of Multiple Drugs

NEW YORK, NY / ACCESSWIRE / September 22, 2022 / Laxxon Medical Corp., a U.S.-based pharma-technology company pioneering 3D screen...

Evonik Industries and Laxxon Medical See Future In 3D Screen Printed Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / March 8, 2022 / Evonik Industries AG, a leading global supplier of specialty chemicals, announced Monday...

3D Screen Printing Enables QR codes on Pharmaceutical Dosage Forms in Mass Production

Marcel Enke, Klaus Kühne, Stefan Seyferth, Dagmar Fischer and Achim Schneeberger. Corresponding author: Achim Schneeberger, Laxxon...

Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference

NEW YORK, NY / ACCESSWIRE / January 7, 2022 / Laxxon Medical Corporation announced today that management would conduct one-on-one...

Third Quarter Management Report

3rd Quarter Management Report November 15, 2021 EXECUTIVE SUMMARY NEW YORK, New York, Nov. 15, 2021 – Q3 was a steadfast and successful...

Scalable 3D Screen Printing - High Degree of Freedom in Terms of Drug Choice

Commentary Additive manufacturing has the potential to revolutionize the pharmaceutical industry, enabling the production of customized...

3D Screen Printing – An Innovative Technology For Manufacturing of Pharmaceutical Dosage Forms

Journal Homepage: www.elsevier.com/locate/ijpharm Article Info Keywords: 3D printing, Additive manufacturing, Controlled release,...

Laxxon Optimizes the Release of Active Substances Thanks to a Patented 3D Screen Printing Process

Laxxon optimiert die Wirkstoffabgabe von Arzneistoffen dank eines patentierten, innovativen 3D Siebdruckverfahrens. Das...

"Nucleus Jena" Project: First Successes Can Be Demonstrated

Projekt „Nucleus Jena“: Erste Erfolge vorweisbar Das Projekt „Nucleus Jena“ von Universität und Hochschule in Jena kann nach einem halben...